41
Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )
Condition(s):OsteoporosisLast Updated:August 12, 2009Terminated
ALENDRONATE SODIUM: 219 Clinical Trials, Page 5 of 22
Hide Studies Not Open or Pending
42
Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease
Condition(s):Vascular Calcification; ArteriosclerosisLast Updated:February 9, 2010Completed
43
The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover
Condition(s):Erosive OsteoarthritisLast Updated:April 22, 2022Completed
44
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
Condition(s):Stage IV Prostate Cancer; Bone Metastases; Adenocarcinoma of the Prostate; Recurrent Prostate CancerLast Updated:April 22, 2014Terminated
45
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.
Condition(s):Osteoporosis; OsteopeniaLast Updated:January 24, 2011Completed
46
Bisphosphonate and Anastrozole Trial – Bone Maintenance Algorithm Assessment
Condition(s):Breast CancerLast Updated:March 13, 2013Completed
47
A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density
Condition(s):Postmenopausal OsteoporosisLast Updated:July 25, 2014Completed
48
A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin D
Condition(s):OsteoporosisLast Updated:February 8, 2022Completed
49
Fosamax for Childhood Cancer Survivors
Condition(s):OsteoporosisLast Updated:May 23, 2008Unknown status
50
A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)
Condition(s):Osteoporosis, PostmenopausalLast Updated:February 3, 2022Completed